Come up with a name for your new list and we'll add to it:
Cebix raised a round of funding on June 21, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Cebix is developing Ersatta, a disease-modifying replacement peptide for the treatment of complications associated with diabetes. Ersatta is a long-acting form of C-peptide that, unlike other products…